EN523

CAS No. 2094893-05-5

EN523 ( —— )

Catalog No. M28951 CAS No. 2094893-05-5

EN523 targets non-catalytic allosteric cysteine C23 in K48 ubiquitin-specific deuquitinase OTUB1.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 147 Get Quote
10MG 260 Get Quote
25MG 520 Get Quote
50MG 750 Get Quote
100MG 1035 Get Quote
500MG 2061 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    EN523
  • Note
    Research use only, not for human use.
  • Brief Description
    EN523 targets non-catalytic allosteric cysteine C23 in K48 ubiquitin-specific deuquitinase OTUB1.
  • Description
    EN523 targets non-catalytic allosteric cysteine C23 in K48 ubiquitin-specific deuquitinase OTUB1.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Nav1.7 channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2094893-05-5
  • Formula Weight
    234.3
  • Molecular Formula
    C12H14N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC1=CC=C(O1)N1CCN(CC1=O)C(=O)C=C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kornecook TJ, et al. Pharmacologic Characterization of AMG8379, a Potent and Selective Small Molecule Sulfonamide Antagonist of the Voltage-Gated Sodium Channel NaV1.7. J Pharmacol Exp Ther. 2017 Jul;362(1):146-160.
molnova catalog
related products
  • Glucotropaeolin pota...

    Glucotropaeolin potassium is found in cruciferous vegetables and moderately decrease spontaneous DNA damage in animals.

  • PXS-5153A

    PXS-5153A is an effective, selective, and fast-acting inhibitor of lysyl oxidase like 2/3 enzymes with enzymatic activity almost entirely blocked within 15 minutes. PXS-5153A could reduce crosslinks and ameliorates fibrosis.

  • Atracurium besylate

    Atracurium besylate is a non-depolarizing neuromuscular blocking agent with short duration of action. Its lack of significant cardiovascular effects and its lack of dependence on good kidney function for elimination provide clinical advantage over alternate non-depolarizing neuromuscular blocking agents.